| Report ID | 205711 |
| Drug Identification Number | 00511552 |
| Brand name | SANDOMIGRAN DS |
| Common or Proper name | SANDOMIGRAN DS 1mg Tabs |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PIZOTIFEN |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 Tabs |
| ATC code | N02CX |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-10-02 |
| Estimated end date | 2026-03-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-16 |
| Company comments | Production delays |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-10-02 | English | Compare |
| v1 | 2023-10-02 | English | Compare |